Advertisement

Topics

ChondroGene Limited Company Profile

00:12 EST 19th December 2018 | BioPortfolio

ChondroGene was formed in 1998 with the bringing together of its two key founders; Dr. K. Wayne Marshall, a noted orthopaedic surgeon and knee specialist and Dr. C.C. Liew, an internationally recognized leader in the area of tissue-specific functional genomics. Their respective expertise was combined to focus on developing new drugs and tests for osteoarthritis (OA), a chronic condition which affects the joints of millions of individuals worldwide, resulting in diminished quality of life for patients and severe economic burdens on healthcare systems.
The Company initially focussed on the use of functional genomics to characterize the molecular activity in tissues that make up the joints in the human body - cartilage, synovium and synovial fluid. The goal was to examine how the tissues of the joint function in different stages of osteoarthritis; from normal joints, to moderately diseased joints, all the way to severe osteoarthritis which could only be treated by total joint replacement. This work culminated in 2001 with the substantial completion of the identification and characterization of the chondrocyte genome (genes expressed in healthy and diseased human cartilage cells). The Company then produced the first known cDNA microarray specifically targeted at human cartilage gene expression, the ChondroChip™, an important platform tool that the Company is using to advance its research efforts in osteoarthritis. At the same time, the Company has applied the Sentinel Principle, a blood-based biomarker approach originally developed by Dr. Liew, to measure RNA expression in blood that can be used to detect and diagnose a variety of diseases and medical conditions throughout the body.

Location

800 Petrolia Road, Unit 15
Toronto
Ontario
M3J 3K4
Canada

Contact

Phone: 416-650-0060
Fax: 416-650-0055
Email: contact@chondrogene.com


News Articles [32 Associated News Articles listed on BioPortfolio]

Quotient Limited Announces Details of Investor Day

JERSEY, Channel Islands, July 16, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced details of its investor day held at the NASDAQ he...

Quotient Limited to Host Investor Day on July 16, 2018

JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it will host an Investor Day on Monday, July ...

Quotient Limited Announces Completion of Senior Secured Notes Offering

JERSEY, Channel Islands, July 02, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), has completed the offering of up to $120.0 million ...

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the Company intends to commence an ...

Quotient Limited to Participate in the Jefferies 2018 London Healthcare Conference

JERSEY, Channel Islands, Oct. 31, 2018 (GLOBE NEWSWIRE) -- Quotient (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the Company's Chief Financial Officer, Chris Lindop,...

Quotient Limited Announces Initial MosaiQ™ SDS Verification and Validation Data

JERSEY, Channel Islands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (the Company), today reported positive Verification and Validation...

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

JERSEY, Channel Islands, Dec. 06, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT) (the Company), a commercial-stage diagnostics company, today announced the pricing of its previously annou...

Quotient Limited Reports Concordance Data from the MosaiQ European Field Trial

Field trial concordance data exceed targeted criteriaPlanned issuance of $36 million in Senior Secured Notes JERSEY, Channel Islands, June 18, 2018 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QT...

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [87 Associated Companies listed on BioPortfolio]

ChondroGene

ChondroGene is a genomics-based company focused on the discovery and development of disease-specific therapeutic and diagnostic approaches, specializing in osteoarthritis. The Company has constructed ...

Microsulis Medical Limited

Founded in 1997, Microsulis Medical Limited is a UK-based medical device company that exploits specialist intellectual property in medical microwave design to create therapeutic d...

ChondroGene Limited

ChondroGene was formed in 1998 with the bringing together of its two key founders; Dr. K. Wayne Marshall, a noted orthopaedic surgeon and knee specialist and Dr. C.C. Liew, an internationally recogniz...

Immunocore Limited

Immunocore Limited is developing innovative biological therapeutics to treat a range of cancers, chronic viral infections and diabetes. Immunocore is a privately owned biotechnology company located ...

SIEMENS CANADA LIMITED

More Information about "ChondroGene Limited" on BioPortfolio

We have published hundreds of ChondroGene Limited news stories on BioPortfolio along with dozens of ChondroGene Limited Clinical Trials and PubMed Articles about ChondroGene Limited for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ChondroGene Limited Companies in our database. You can also find out about relevant ChondroGene Limited Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Arthritis
Arthritis is by definition the inflammation of one or more joints, characterized by swelling, pain, warmth, redness and diminished range of joint movement (Oxford Medical Dictionary). There are many different types; Noninflammatory; Osteoarthritis, N...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Rheumatology
Arthritis Fibromyalgia Gout Lupus Rheumatic Rheumatology is the medical specialty concerned with the diagnosis and management of disease involving joints, tendons, muscles, ligaments and associated structures (Oxford Medical Diction...


Corporate Database Quicklinks



Searches Linking to this Company Record